Medical AI Alliance
← Company Index
Medical DevicesKOSDAQ 30336040 approvals

PROTIA INC.

Official website

KOSDAQ-listed in-vitro diagnostics company selling PROTIA Allergy-Q allergy diagnostic products domestically and in 80+ countries.

As of 2026-10-10, PROTIA INC. has 40 Korean MFDS device approvals, 2 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 2000 and listed on KOSDAQ in 2023, PROTIA is an in-vitro diagnostics medical device company. It sells the PROTIA Allergy-Q human allergy diagnostic line, ANITIA companion-animal allergy tests, food intolerance diagnostics, capacitance-based antibiotic susceptibility tests (Q-AST, PROTIA AST DL001), and autoimmune disease diagnostics. Its allergy diagnostic products hold over 45% domestic market share and reach 80+ countries through roughly 90 distributors, with new products developed under patent acquisition agreements with Yonsei University's industry-academic cooperation foundation.

Products & technology

  • PROTIA Allergy-Q serieshuman allergy diagnostics
  • ANITIAcompanion animal (dog/cat/horse) allergy diagnostics
  • ANITIA Canine Food Intolerance Test 128canine food intolerance diagnostics
  • PROTIA AST / Q-AST 192 Proantibiotic susceptibility testing
  • IMSAFE Salivasalivary IgA immune antibody measurement

Regulatory approvals

data.go.kr

40 Korean MFDS device approvals · 2014–2025

  • MFDSIVD reagents for allergy test2025-03-17
    Product approval · Class 2체외 제인 25-4206 호
  • MFDSIVD reagents for allergy test2024-12-30
    Product approval · Class 2체외 제인 24-1197 호
  • MFDSIVD reagents for allergy test2024-12-30
    Product approval · Class 2체외 제인 24-1196 호
  • MFDSIVD reagents for allergy test2024-07-19
    Product approval · Class 2체외 제인 24-702 호
  • MFDSIVD reagents for allergy test2024-07-19
    Product approval · Class 2체외 제인 24-701 호
  • MFDSIVD reagents for allergy test2024-04-26
    Product approval · Class 2체외 제인 24-441 호
  • MFDSMicrobial susceptibility testing analyzer2024-01-29
    Product approval · Class 1체외 제신 24-131 호
  • MFDSIVD reagents for autoimmune disease2023-01-12
    Product approval · Class 2체외 제인 23-4057 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological methodRevoked2022-09-29
    Product approval · Class 3체외 제허 22-651 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological methodRevoked2022-07-08
    Product approval · Class 3체외 제허 22-440 호
  • MFDSIVD reagents for allergy test2022-06-02
    Product approval · Class 2체외 제인 22-4425 호
  • MFDSIVD reagents for allergy test2022-05-18
    Product approval · Class 2체외 제인 22-4388 호
Show 28 more
  • MFDSIVD reagents and media for antibiotic susceptibility2022-05-18
    Product approval · Class 2체외 제인 22-4386 호
  • MFDSFluorimetric immunoassay analyzer(FIA), stationary2022-04-15
    Product approval · Class 1체외 제신 22-505 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological methodRevoked2022-02-09
    Product approval · Class 3체외 제허 22-84 호
  • MFDSMicrobial susceptibility testing analyzerRevoked2021-08-11
    Product approval · Class 1체외 제신 21-1101 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnosticsRevoked2021-01-12
    Product approval · Class 3체외 제허 21-22 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnosticsRevoked2020-07-15
    Product approval · Class 3체외 제허 20-570 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological methodRevoked2020-06-05
    Product approval · Class 3체외 제허 20-448 호
  • MFDSIVD reagents for allergy test2019-12-20
    Product approval · Class 2체외 제인 19-5034 호
  • MFDSIVD reagents for allergy test2019-08-28
    Product approval · Class 2체외 제인 19-4723 호
  • MFDSMicrobial identification analyzer2019-07-18
    Product approval · Class 1체외 제신 19-996 호
  • MFDSIVD reagents and media for antibiotic susceptibility2019-05-23
    Product approval · Class 2체외 제인 19-4415 호
  • MFDSPhotometer for clinical use2019-05-20
    Product approval · Class 1체외 제신 19-644 호
  • MFDSClinical IVD strip for endocrine, related to pregnant2019-04-04
    Product approval · Class 2체외 제인 19-4257 호
  • MFDSBlood sample preparation instruments, general2019-02-22
    Product approval · Class 1체외 제신 19-244 호
  • MFDSMicrobial susceptibility testing analyzer2018-12-14
    Product approval · Class 1체외 제신 18-1671 호
  • MFDSIVD reagents for allergy test2018-08-08
    Product approval · Class 2체외 제인 18-4635 호
  • MFDSImmunoabsorbance analyzer2017-08-25
    Product approval · Class 1체외 제신 17-990 호
  • MFDSIVD reagents for allergy test2017-06-07
    Product approval · Class 2체외 제인 17-4439 호
  • MFDSIVD reagents for allergy test2017-04-06
    Product approval · Class 2체외 제인 17-4256 호
  • MFDSSpectrophotometer for clinical use2017-01-12
    Product approval · Class 1체외 제신 17-44 호
  • MFDSGeneral calibrators, controls or standards, classⅠ, for clinical chemistry2016-04-07
    Product approval · Class 1체외 제신 16-419 호
  • MFDSIVD strip for endocrine self test2016-01-25
    Product approval · Class 2체외 제인 16-46 호
  • MFDSIVD strip for endocrine self test2016-01-25
    Product approval · Class 2체외 제인 16-47 호
  • MFDSChemiluminescence assay(CLIA) analyzer2015-03-18
    Product approval · Class 1서울 체외 제신 15-100 호
  • MFDSSpectrophotometer for clinical use2015-03-10
    Product approval · Class 1서울 체외 제신 15-89 호
  • MFDSIVD reagents for specific protein(immunoglobulin) test2015-03-03
    Product approval · Class 2체외 제허 15-302 호
  • MFDSIVD strip for endocrine self test2014-11-11
    Product approval · Class 2체외 제인 14-1978 호
  • MFDSIVD reagents for allergy test2014-03-18
    Product approval · Class 2체외 제인 14-644 호

Key disclosures

KRX KIND via OpenDART

Publications

PubMed · affiliation-matched

Patents

KIPRIS · applicant-matched
Show 79 more patents

AI reads

MAA server logs · IP-verified
69
Times AI engines pulled PROTIA INC.'s records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

1
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

68
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

6
live 0
Last 7 days
50
live 0
Last 30 days
69
live 1
All time
  • OpenAIChatGPT-Userlive1
  • OpenAIOAI-SearchBot52
  • GoogleGoogleOther11
  • PerplexityPerplexityBot3
  • AnthropicClaudeBot2

Measured since Aug 27, 2026 · 4 AI engines · last read Oct 9, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for PROTIA INC. and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview · R&D. Send us materials and we will add them

Companies approved for the same productsMedical Devices

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

GC Medical Science Corporation15 shared

GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.

Sugentech, Inc.13 shared

Founded in 2011 and KOSDAQ-listed in 2019, Sugentech develops multiplex immunoblot, point-of-care, and digital healthcare diagnostics.

Boditech Med Inc.12 shared

KOSDAQ-listed point-of-care immunodiagnostics company supplying diagnostic cartridges and the ichroma/AFIAS instrument series.

SD BIOSENSOR INC.10 shared

KOSPI-listed in-vitro diagnostics company known for the STANDARD Q antigen/antibody test kits.

NanoenTek,Inc.8 shared

Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.

OSANG HEALTHCARE CO.,LTD.7 shared

Founded 1996, listed on KOSDAQ in 2024, OSANG HEALTHCARE develops and sells biochemistry, immunodiagnostic, and molecular IVD products.

Access Bio, Inc.7 shared

Founded in 2002 and KOSDAQ-listed in 2013, Access Bio develops rapid diagnostic tests for malaria, COVID-19, and other infectious diseases.

HUMASIS CO., LTD.5 shared

KOSDAQ-listed IVD company producing COVID-19 and HIV point-of-care diagnostic reagents alongside rubber products and entertainment businesses.

Precision Biosensor Inc.5 shared

KOSDAQ-listed IVD company producing time-resolved fluorescence immunodiagnostic products under the Exdia TRF brand.

PCL. Inc5 shared

KOSDAQ-listed IVD company using SG Cap™ multiplex diagnostic technology for infectious disease, cancer, and companion animal testing.

GENEMATRIX INC.5 shared

KOSDAQ-listed biotech company developing molecular diagnostics with proprietary C-Tag technology and the NeoPlex product line.

CALTH. Inc5 shared

Holds manufacturing approvals for 42 point-of-care diagnostic reagents and devices in the IVD market.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition